Aplotaxene blocks T cell activation by modulation of protein kinase C-theta-dependent pathway

作者：Na Bo Ra; Kim Hye Ran; Kwon Min Sung; Lee Hyun Su; Piragyte Indre; Choi Eun Ju; Choi Hyun Kyu; Han Weon Cheol; Lee Seung Ho; Jun Chang Duk^*

来源：Food and Chemical Toxicology, 2013, 62: 23-31.

DOI：10.1016/j.fct.2013.08.016

• Aplotaxene
• Immunosuppression
• IL-2
• T cell activation
• Protein kinase C-theta

Aplotaxene, (8Z, 11Z, 14Z)-heptadeca-1, 8, 11, 14-tetraene, is one of the major components of essential oil obtained from Inula helenium root, which is used in Oriental medicine. However, the effects of aplotaxene on immunity have not been investigated. Here, we show that aplotaxene inhibits T cell activation in terms of IL-2 and CD69 expression. Aplotaxene, at a concentration that optimally inhibits IL-2 production, has little effect on apoptotic or necrotic cell death, suggesting that apoptosis is not a mechanism for aplotaxene-mediated inhibition of T cell activation. Aplotaxene affects neither superantigeninduced conjugate formation between Jurkat T cells and Raji B cells nor clustering of CD3 and LFA-1 at the immunological synapse. Aplotaxene significantly inhibits PKC-theta phosphorylation and translocation to the immunological synapse, and blocks PMA-induced T-cell receptor internalization. Furthermore, aplotaxene leads to inhibition of mitogen-activated protein kinases (INK, ERK and p38) phosphorylation and NF-kappa B, NF-AT, and AP-1 promoter activities in Jurkat T cells. Taken together, our findings provide evidence for the immunosuppressive effect of aplotaxene on activated T cells through the modulation of the PKC-theta and MAPK pathways, suggesting that aplotaxene may be a novel immunotherapeutic agent for immunological diseases related to the overactivation of T cells.

• 出版日期2013-12